WO2002098490A1 - Hemodialyzer having improved dialysate perfusion - Google Patents

Hemodialyzer having improved dialysate perfusion Download PDF

Info

Publication number
WO2002098490A1
WO2002098490A1 PCT/US2002/013043 US0213043W WO02098490A1 WO 2002098490 A1 WO2002098490 A1 WO 2002098490A1 US 0213043 W US0213043 W US 0213043W WO 02098490 A1 WO02098490 A1 WO 02098490A1
Authority
WO
WIPO (PCT)
Prior art keywords
dialysate
dialyzer
interior
inlet
flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/013043
Other languages
English (en)
French (fr)
Inventor
Randolph H. Watkins
James S. Slepicka
Michael R. Prisco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Priority to MXPA03010988A priority Critical patent/MXPA03010988A/es
Priority to DE60227076T priority patent/DE60227076D1/de
Priority to EP02776553A priority patent/EP1406685B1/en
Priority to JP2003501527A priority patent/JP4036828B2/ja
Publication of WO2002098490A1 publication Critical patent/WO2002098490A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/02Hollow fibre modules
    • B01D63/021Manufacturing thereof
    • B01D63/0233Manufacturing thereof forming the bundle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1621Constructional aspects thereof
    • A61M1/1623Disposition or location of membranes relative to fluids
    • A61M1/1627Dialyser of the inside perfusion type, i.e. blood flow inside hollow membrane fibres or tubes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/20Accessories; Auxiliary operations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/04Liquids
    • A61M2202/0496Urine
    • A61M2202/0498Urea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/15Detection of leaks
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/10Specific supply elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/12Specific discharge elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/21Specific headers, end caps

Definitions

  • the present invention relates generally to medical treatments. More specifically, the present invention relates to dialysis therapies and dialyzers.
  • the renal system can fail. In renal failure of any cause, there are several physiological derangements. The balance of water, minerals (Na, K, Cl, Ca, P, Mg, SO ) and the excretion of daily metabolic load of fixed hydrogen ions is no longer possible in renal failure. During renal failure, toxic end products of nitrogen metabolism (urea, creatinine, uric acid, and others) can accumulate in blood and tissues.
  • Dialysis processes have been devised for the separation of elements in a solution by diffusion across a semi-permeable membrane (diffusive solute transport) down a concentration gradient. Principally, dialysis comprises two methods: hemodialysis; and peritoneal dialysis.
  • Hemodialysis treatment utilizes the patient's blood to remove waste, toxins, and excess water from the patient.
  • the patient is connected to a hemodialysis machine and the patient's blood is pumped through the machine.
  • Catheters are inserted into the patient's veins and arteries to connect the blood flow to and from the hemodialysis machine. Waste, toxins, and excess water are removed from the patient's blood and the blood is infused back into the patient.
  • Hemodialysis treatments last several hours and are generally performed in a treatment center about three to four times per week.
  • Hemodialysis typically involves the use of a dialyzer.
  • Dialyzers generally comprise a housing or casing. Located within the interior of the casing is a fiber bundle.
  • the fiber bundle is comprised of a number of membranes that are oriented parallel to each other.
  • the membranes are designed to allow blood to flow therethrough with dialysate flowing on the outside of the membranes. Due to an osmotic gradient that is created, waste products are removed from the blood through the membranes into the dialysate.
  • dialyzers typically include a blood inlet and a blood outlet.
  • the blood inlet is designed to cause blood to enter the fiber membranes and flow therethrough through the blood outlet.
  • Dialysate is designed to flow through an inlet of the dialyzer and out of the dialyzer through an outlet.
  • the dialysate is designed to flow across the outside or exterior walls of the membranes.
  • dialysate may not flow sufficiently around the entire fiber bundle. Rather shunts between the bundle and the case may occur. This can result in a reduced flow of dialysate around certain portions of membranes contained in the center of the fiber bundle. The clearance of the dialyzer will therefore be reduced.
  • the present invention provides improved dialyzers and methods for providing dialysis.
  • the present invention provides a dialyzer having an improved perfusion of dialysate into the fiber bundle.
  • a dialyzer comprising a casing defining an interior and including a dialysate inlet and a dialysate outlet.
  • a plurality of fibers are located in the interior of the casing and define a fiber bundle.
  • a dialysate inlet fluid channel is provided in fluid communication with the dialysate inlet and includes a plurality of flutes that extend into a portion of the fiber bundles, the flutes define an opening for allowing dialysate to flow from the inlet fluid channel into the interior of the casing.
  • the dialyzer includes a dialysate outlet fluid channel in fluid communication with the dialysate outlet that includes a plurality of flutes that extend into a portion of the fiber bundle.
  • the flutes define openings for allowing dialysate to flow from the interior of the casing into the dialysate outlet fluid channel.
  • the outlet fluid channel and inlet fluid channel have substantially the same structure.
  • the casing is constructed from plastic.
  • the dialyzer includes eight flutes.
  • a top portion of the dialysate inlet is defined by potting material.
  • the flutes circumscribe an entire circumference of a first end of the dialyzer.
  • the opening in the flutes is a slot.
  • each flute defines a separate opening.
  • a dialyzer comprising a casing defining an interior and having a first end having a dialysate inlet and a second end having a dialysate outlet.
  • a fiber bundle including a plurahty of fibers is located within the interior and extends from the first end to the second end.
  • a fluid inlet channel in fluid communication with the dialysate inlet is provided, the fluid inlet channel being defined, in part, by a portion of the casing that defines an exterior surface of the first end and an inner wall that circumscribes a portion of the interior.
  • the inner wall includes portions that extend into the fiber bundle. At least one of the portions includes an aperture for allowing fluid to flow from the channel into the interior.
  • a fluid outlet channel in fluid communication with the dialysate outlet is provided.
  • the fluid outlet channel is defined, in part, by a portion of the casing that defines an exterior surface of the first end and an inner wall that circumscribes a portion of the interior.
  • the inner wall includes portions that extend into the fiber bundle, at least one of the portions including an aperture for allowing fluid to flow from the channel into the interior.
  • the inner wall defines a pluality of semicircular structures.
  • the fluid inlet channel and fluid outlet channel includes at least six separate portions that extend into the fiber bundle each including an aperture.
  • a dialyzer comprising a casing defining an interior having a fiber bundle located therein and including a first end having a dialysate inlet and a second end having a dialysate outlet.
  • the casing including a dialysate inlet in fluid communication with an inlet fluid channel, the inlet fluid channel defined, at least in part, by an interior wall of the casing, a potting material and an inner wall circumscribing the interior of the first end.
  • the inner wall includes a plurality of members defining areas for receiving fibers of the fiber bundle and a portion that extends into the fiber bundles. Each of the portions of the inner wall that extend into the fiber bundles and include an aperture for allowing dialysate to flow into the interior of the casing.
  • the portions define flutes.
  • a method for providing dialysis to a patient comprising the steps of passing blood through fiber bundles of a dialyzer and passing dialysate through the dialyzer such that the dialyzer includes portions that separate a portion of the fiber bundle causing more dialysate to flow to an interior of the fiber bundle.
  • a further advantage of the present invention is to provide an improved method of providing dialysis to a patient.
  • an advantage of the present invention is to provide an improved housing design for a dialyzer. Furthermore, an advantage of the present invention is to provide improved fluid flow characteristics in a dialyzer.
  • an advantage of the present invention is to provide a dialyzer having improved efficiency.
  • Another advantage of the present invention is to provide an improved dialyzer for hemodialysis.
  • an advantage of the present invention is to provide an improved dialyzer that can be used in a number of therapies.
  • Figure 1 illustrates a perspective view of an embodiment of a dialyzer of the present invention.
  • Figure 2 illustrates a top elevation view of an embodiment of the dialyzer of the present invention.
  • Figure 3 illustrates the dialyzer of Figure 2 with the fiber bundle removed.
  • Figure 4 illustrates a side elevation view of the dialyzer of Figure 3.
  • Figure 5 illustrates a cross-sectional view of the dialyzer of Figure 4.
  • the present invention provides improved dialyzers and methods of using same.
  • the dialyzer is designed for use in hemodialysis, it should be noted that the dialyzer can be used in a number of different therapies.
  • the dialyzer can be used in non-traditional hemodialysis methods. Such methods include, for example, regeneration and continuous flow therapies which may or may not include hemodialysis, for example, continuous flow peritoneal dialysis.
  • the present invention in an embodiment, can be utilized in methods of providing dialysis for patients having chronic kidney failure or disease, the present invention can be used for acute dialysis needs, for example, in an emergency room setting. Referring now to Figure 1, a dialyzer 10 is generally illustrated. The dialyzer 10 is generally illustrated. The dialyzer
  • the 10 includes a body member 12 that generally comprises a casing.
  • the casing includes a core section 14 as well as two bell members 16 and 18 located at each end of the dialyzer 10.
  • Located within the core or casing is a fiber bundle 20.
  • the fiber bundle 20 includes a plurality of hollow fiber membranes.
  • the membranes are semi-permeable having a selective permeability.
  • the membranes are bundled together and assembled in the casing in a manner allowing blood to flow simultaneously in a parallel manner through the lurnina of the fibers while a blood cleansing liquid (dialysate) is simultaneously passed through the casing. In theory, this allows the dialysate to bathe the exterior surface of the hollow fibers.
  • a variety of compounds can be used to produce selective permeable membranes including polymers such as: cellulose; cellulose acetate; polyamide; polyacrylonitearliest; polyvinyl alcohol; polymethacrylate; polysulfone; and polyolefin.
  • the fiber bundle 20 is encapsulated at each end of the dialyzer to prevent blood flow around the fibers.
  • a fluid inlet 22 Located at a first end of the dialyzer is a fluid inlet 22 and at a second end a fluid outlet 24 defined by a fluid inlet header 26 and a fluid outlet header 28.
  • a variety of header designs can be utilized.
  • the inlet header 26 and outlet header 28 have designs such as those set forth in U.S. Patent Application Serial No. entitled “Hemodialyzer Headers” being filed herewith, the disclosure of which is hereby incorporated by reference.
  • any header design can be utilized.
  • the dialyzer body 10 also includes a dialysate inlet 30 and a dialysate outlet 32.
  • the dialysate inlet 30 and dialysate outlet 32 define fluid flow channels that are in a radial direction, i.e., perpendicular to the fluid flow path of the blood.
  • the dialysate inlet 30 and dialysate outlet 32 are designed to allow dialysate to flow into an interior 34 of the dialyzer bathing the exterior surfaces of the fibers and the fiber bundle 20 and then out through the outlet 32. This, as is known in the art, causes waste and other toxins to be removed from the blood through the semipermeable membrane of the fibers and carried away by the dialysate.
  • an improved inlet and/or outlet design is provided. This provides for improved perfusion of the dialysate through the fiber bundle.
  • three mass transfer resistances must be minimized. These mass transfer resistances include: 1) blood resistance; 2) membrane resistance; and 3) dialysate resistance.
  • the dialysate resistance is dictated, in part, by the case design, fiber packing density, and effective shape of the fluid flow path.
  • the bells and dialysate inlet and outlet have straight walls that surround the hollow fiber.
  • the dialysate inlet 30 and dialysate outlet 32 of the dialyzer of the present invention provide a design that reduces shunting.
  • the design also improves dialysate perfusion into the bundle 20.
  • the fiber ends do not deflect outwardly into the chamber of the larger inner diameter of the bell of the core as in prior art designs. Instead, structures are provided causing the outer fibers to be pulled away from the bundle. This provides improved access to the bundle core.
  • the present invention provides an inlet fluid flow channel 38 defined by an outer wall 40, an inner wall 42 and the top wall (not shown) defined by potting material that seals the fiber bundle, as is known in the art.
  • the inlet fluid channel 34 preferably extends below and above the dialysate inlet 30. Thus, dialysate will enter the inlet fluid channel 34 through the dialysate inlet 30 and flow around the channel into the dialyzer.
  • the outer wall 40 also defines the exterior of the casing of the dialyzer 10.
  • the interior wall 42 with the outer wall 40, defines the inlet flow channel 38.
  • the inner wall also includes a plurality of flutes, in the illustrated embodiment eight flutes 50, 52, 54, 56, 58, 60, 62, and 64. In the preferred embodiment illustrated, these flutes 50, 52, 54, 56, 58, 60, 62, and 64 define semicircular structures.
  • the flutes define openings 51, 53, 55, 57, 59, 61, 63, and 65. In the preferred embodiment illustrated, the opening is a slot shape. However, a variety of openings can be utilized. The openings allow the dialysate that flows through the inlet flow channel 38 to enter an interior 34 of the dialyzer 10.
  • the space between the outer wall 40 of the dialyzer 10 and the inner wall 42 that defines the flutes 50, 52, 54, 56, 58, 60, 62, and 64 is sufficient to allow ample dialysate to flow through the slots 51, 53, 55, 57, 59, 61, and 63 without a significant pressure drop.
  • the slot widths can be varied depending on the position and order of the slots to account for circumferential differences in potting depth that may occur from the potting procedure. This allows the flow rate to be equal at all slot locations.
  • flutes 50, 52, 54, 56, 58, 60, 62, and 64 are provided, and therefore eight openings or slots 51, 53, 55, 57, 59, 61, and 63, more or less flutes can be provided. However, it is believed that eight may be the ideal number.
  • the outlet end 70 of dialyzer 10 includes a structure similar to that of the dialysate inlet.
  • the dialysate outlet 70 will include a dialysate outlet channel (not shown) similar to the dialysate inlet flow channel 38.
  • the dialysate outlet 70 can be of a standard bell structure as is known in the prior art. But, certain advantages are achieved by creating the dialysate outlet that is substantially identical to the dialysate inlet, including ease of manufacturing.
  • Tables 1 and 2 show the reduction in urea clearance with dialysate shunts for a 2.0 square meter and a 2.4 square meter dialyzer.
  • the overall mass transfer coefficient has been adjusted downward to account for the lower dialysate side mass transfer coefficient due to the reduced effective dialysate flow caused by the shunt. It can be seen from these two tables that a large dialysate shunt can dramatically reduce the clearance of a dialyzer.
  • Urea clearance as a function of percentage dialysate shunt for a 2.0 square meter dialyzer with 300 ml/min blood flow and 500 ml min dialysate flow is reduced from 269 ml/min to 229 ml/min by a 40% dialysate shunt.
  • the clearance drops from 278 ml min to 238 ml/min due to a 40% shunt.
  • This analysis can also be used to predict the increase in clearance of a dialyzer if a shunt of known magnitude is eliminated. From a measured or calculated clearance value and an assumed shunt magnitude, the overall mass transfer coefficient of the dialyzer can be determined from the preceding equations. Using this calculated value of K and assuming the elimination of the assumed shunt, the improved clearance can be calculated. Table 3 shows the predicted urea clearances of 1.3, 1.6, 1.8 and 2.0 square meter dialyzers where 0%, 10%, 15 % and 20% shunt have been eliminated for a blood flow of 300 ml/min and dialysate flow rate of 500 ml/min.
  • Line 1 provides the urea clearance of a dialyzer without maladistributions.
  • Line 2 provides the urea clearance of a dialyzer with blood flow 10% higher.
  • Line 3 is the urea clearance with 10% lower blood flow.
  • the clearance of this dialyzer will be the average of the clearances on lines 2 and 3 which is shown on line 4.
  • the urea clearance is only reduced from 268.8 to 267.6 ml/min., a minor reduction.
  • Lines 5, 6 and 7 of Table 4 set forth a 10% variation in dialysate flow that was added to the 10% blood flow variation with the higher blood flow occurring where the dialysate flow is lower (as what might occur near the center of the bundle).
  • the urea clearance dropped further to 265.8 ml/min.
  • Table 6 provides similar results for 500ml/min blood flow and 800 ml/min dialysate flow. Here a 20% dialysate maldistribution results in a clearance reduction from 409.6 ml/min (line 4) to 402.7 ml/min (line 10).
  • dialysate flow distributions are quite non-uniform for the regions adjacent to the flow inlet and outlet.
  • the distributions of dialysate flow for the dialyzer header designs of the present invention are more uniform than the conventional dialyzer.
  • a porous medium model is used here for modeling the over-all flow and pressure distributions in the fiber-bundle. The model assumes that there is a local balance between pressure and resistance forces in the flow domain such that:
  • Kj is the permeability and Uj is the superficial velocity in direction ⁇ ,-. (The volume flow rate divided by the total cross-sectional area.)
  • the permeability Kj is computed by the following equation:
  • Ki cti lu l + ⁇ ,- where CCJ and ⁇ ,- are constants for a particular flow, U is the superficial velocity vector. It is noted that the permeability in Darcy's law is defined as: where K J is the permeability and is equal to ⁇ /Kj.
  • the flow in the dialyzer is assumed to be laminar, steady state, incompressible, and Newtonian.
  • the permeability for the porous-medium flow model should be derived from the flow pressure drop in the fiber-bundle measured experimentally. However, the experimental data are not available.
  • the other alternative is to solve for the pressure distributions numerically. First it is assumed that the fibers are arranged in a fixed staggered pattern. The space in between the fibers is computed from the given fiber packing factor. The blood flow in a dialyzer is inside the hollow fibers.
  • the porous medium flow permeability along the axial-direction is computed based on the pressure drop for a fully developed laminar pipe flow. The permeability is infinite for cross flow.
  • the pressure drop is computed numerically for flow in several layers of fibers. Then the flow permeability is calculated from the computed pressure gradient for the particular fiber configuration.
  • the axial flow pressure drop is different from the cross-flow pressure drop and the flow in each direction is computed separately.
  • porous medium model is only an approximation for the actual complicated flow problem.
  • the fiber distributions in a dialyzer are usually non-uniform and the flow permeability varies spatially.
  • dialyzer design was analyzed. The first is an elongated version of the prior art dialyzer and the second is the present invention dialyzer.
  • the input parameters for both cases are presented in Table 7.
  • dialysate is introduced to the bundle in the inlet bell, where all the fibers along the bundle perimeter are exposed.
  • dialyzer there are eight slots in the inlet bell region through which dialysate is introduced to adjacent sections of the fiber bundle. The width and length of the slots are 0.031" and 0.294", respectively.
  • the bell configurations for the opposite (outlet) end of each dialyzer are the same as the respective inlets.
  • dialyzer at a dialysate flow rate of 500 ml/min, the dialysate flow velocity is uniform adjacent to the flow inlet and outlet showing a 6% difference between the maximum and the minimum values. In the mid-section of the bundle, there exists a 0.5% flow variation. Flow characteristics for this dialyzer are also shown for a dialysate flow rate of 1000 ml/min.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Water Supply & Treatment (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Manufacturing & Machinery (AREA)
  • External Artificial Organs (AREA)
PCT/US2002/013043 2001-06-01 2002-04-24 Hemodialyzer having improved dialysate perfusion Ceased WO2002098490A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MXPA03010988A MXPA03010988A (es) 2001-06-01 2002-04-24 Hemodializador que tiene perfusion mejorada del dializado.
DE60227076T DE60227076D1 (de) 2001-06-01 2002-04-24 Hämodialysator mit verbesserter dialysatperfusion
EP02776553A EP1406685B1 (en) 2001-06-01 2002-04-24 Hemodialyzer having improved dialysate perfusion
JP2003501527A JP4036828B2 (ja) 2001-06-01 2002-04-24 改善された透析液灌流を有する血液透析機

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/871,864 US6623638B2 (en) 2001-06-01 2001-06-01 Hemodialyzer having improved dialysate perfusion
US09/871,864 2001-06-01

Publications (1)

Publication Number Publication Date
WO2002098490A1 true WO2002098490A1 (en) 2002-12-12

Family

ID=25358329

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/013043 Ceased WO2002098490A1 (en) 2001-06-01 2002-04-24 Hemodialyzer having improved dialysate perfusion

Country Status (9)

Country Link
US (1) US6623638B2 (enExample)
EP (1) EP1406685B1 (enExample)
JP (2) JP4036828B2 (enExample)
AR (1) AR033170A1 (enExample)
AT (1) ATE397946T1 (enExample)
DE (1) DE60227076D1 (enExample)
MX (1) MXPA03010988A (enExample)
TW (1) TW553751B (enExample)
WO (1) WO2002098490A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2954944A1 (de) 2014-06-12 2015-12-16 B. Braun Avitum AG Dialysator mit einem bündel an hohlfasern sowie verfahren zum herstellen einer solchen hohlfaser

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254513A1 (en) 2002-04-10 2004-12-16 Sherwin Shang Conductive polymer materials and applications thereof including monitoring and providing effective therapy
US7022098B2 (en) 2002-04-10 2006-04-04 Baxter International Inc. Access disconnection systems and methods
US7052480B2 (en) 2002-04-10 2006-05-30 Baxter International Inc. Access disconnection systems and methods
US10155082B2 (en) 2002-04-10 2018-12-18 Baxter International Inc. Enhanced signal detection for access disconnection systems
WO2005062973A2 (en) * 2003-12-24 2005-07-14 Chemica Technologies, Inc. Dialysate regeneration system for portable human dialysis
US9254279B2 (en) 2004-05-12 2016-02-09 Baxter International Inc. Nitric oxide scavengers
US7534349B2 (en) * 2005-09-02 2009-05-19 Nephros, Inc. Dual stage ultrafilter devices in the form of portable filter devices, shower devices, and hydration packs
US7775375B2 (en) * 2005-11-03 2010-08-17 Medica S.R.L. Redundant ultrafiltration device
WO2007138659A1 (ja) 2006-05-26 2007-12-06 National University Corporation Nagoya University 創外固定器
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
EP2280741A4 (en) 2008-04-29 2012-06-13 Virginia Tech Intell Prop IRREVERSIBLE ELECTROPORATION FOR THE PRODUCTION OF TISSUE OBJECTS
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US20100125235A1 (en) * 2008-06-16 2010-05-20 Triaxis Medical Devices, Inc. Blood Treatment Apparatus Having Branched Flow Distribution
JP5216916B2 (ja) * 2008-07-15 2013-06-19 ミリメディカル・リミテッド・ライアビリティ・カンパニー ダブルファイバ束ダイアライザ
US8114043B2 (en) 2008-07-25 2012-02-14 Baxter International Inc. Electromagnetic induction access disconnect sensor
US8632534B2 (en) 2009-04-03 2014-01-21 Angiodynamics, Inc. Irreversible electroporation (IRE) for congestive obstructive pulmonary disease (COPD)
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
WO2010138919A2 (en) 2009-05-28 2010-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
US8388566B2 (en) 2010-04-29 2013-03-05 Sorin Group Italia, S.r.l. Oxygenator with integrated arterial filter including filter frame
EP2612685B1 (en) 2010-08-19 2014-10-08 Sorin Group Italia S.r.l. Blood processing unit with modified flow path
EP2524712B1 (en) 2011-05-17 2018-12-12 Sorin Group Italia S.r.l. Blood processing unit with cross blood flow
WO2012051433A2 (en) 2010-10-13 2012-04-19 Angiodynamics, Inc. System and method for electrically ablating tissue of a patient
WO2012088149A2 (en) 2010-12-20 2012-06-28 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
US9414881B2 (en) 2012-02-08 2016-08-16 Angiodynamics, Inc. System and method for increasing a target zone for electrical ablation
US9888956B2 (en) 2013-01-22 2018-02-13 Angiodynamics, Inc. Integrated pump and generator device and method of use
CN105899245B (zh) 2014-01-09 2018-02-06 索林集团意大利有限责任公司 具有提供修改的流动路径的热交换器芯部的血液处理单元
JP6386580B2 (ja) 2014-02-28 2018-09-05 ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータSorin Group Italia S.r.l. 追加される充填量を最小にする、酸素供給器と一体化される動脈フィルタを提供するためのシステム
EP4335539A3 (en) 2014-03-29 2024-05-01 Princeton Trade and Technology Inc. Blood processing cartridges and systems, and methods for extracorporeal blood therapies
JP6594901B2 (ja) 2014-05-12 2019-10-23 バージニア テック インテレクチュアル プロパティース インコーポレイテッド パルス電界を使用した細胞の細胞内効果の選択的調節
US12114911B2 (en) 2014-08-28 2024-10-15 Angiodynamics, Inc. System and method for ablating a tissue site by electroporation with real-time pulse monitoring
WO2016075514A1 (en) 2014-11-12 2016-05-19 Sorin Group Italia S.R.L. Elastic protection tube for a hollow fibre blood processing apparatus
US10694972B2 (en) 2014-12-15 2020-06-30 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
JP6535108B2 (ja) 2015-05-12 2019-06-26 ソリン・グループ・イタリア・ソシエタ・ア・レスポンサビリタ・リミタータSorin Group Italia S.r.l. ガス交換を減少させるための1つまたは複数の制限要素を有する血液ガス交換器
US10426884B2 (en) 2015-06-26 2019-10-01 Novaflux Inc. Cartridges and systems for outside-in flow in membrane-based therapies
WO2017053805A1 (en) 2015-09-24 2017-03-30 Labib Mohamed E Cartridges for hollow fibre membrane-based therapies
CN105343954B (zh) * 2015-09-25 2018-03-06 珠海健帆生物科技股份有限公司 复合血液净化装置及其制作方法
TW201806631A (zh) * 2016-08-19 2018-03-01 施顯章 血液透析裝置
EP3290100B1 (en) * 2016-08-31 2020-08-19 Gambro Lundia AB Diffusion and/or filtration device
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US12390262B2 (en) 2018-03-13 2025-08-19 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
US11950835B2 (en) 2019-06-28 2024-04-09 Virginia Tech Intellectual Properties, Inc. Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
US12214189B2 (en) 2019-07-24 2025-02-04 Virginia Tech Intellectual Properties, Inc. Fourier analysis spectroscopy for monitoring tissue impedance changes and treatment outcome during electroporation-based-therapies
US12485279B2 (en) 2020-11-25 2025-12-02 Virginia Tech Intellectual Properties, Inc. Methods for modulating temporal infrastructure of pulsed electric fields
CN112472897A (zh) * 2020-12-11 2021-03-12 威海威高血液净化制品有限公司 一种透析器筒体及具有该筒体的透析器

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2839937A1 (de) * 1978-09-14 1980-04-03 Sigdell Jan Erik Dr Hohlfaserdialysator mit dialysatfuehrung
US4219426A (en) * 1976-03-19 1980-08-26 Organon Teknika B.V. Dialysis device
US4220535A (en) * 1978-08-04 1980-09-02 Monsanto Company Multi-zoned hollow fiber permeator
WO1993013941A1 (en) * 1992-01-15 1993-07-22 The Dow Chemical Company Method of forming tube sheet for hollow fibers
US6074559A (en) * 1996-11-21 2000-06-13 Fresenius Medical Care Deutschland Gmbh Filter device having a hollow fiber bundle and associated sealing devices

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202776A (en) 1975-07-28 1980-05-13 Nippon Zeon Co., Ltd. Hollow-fiber permeability apparatus
JPS5322163A (en) 1976-08-12 1978-03-01 Nippon Zeon Co Ltd Mass transfer apparatus of hollow fiber type
DE2646358C2 (de) 1976-10-14 1982-05-13 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG Apparatebau KG, 6380 Bad Homburg Hohlfaserdialysator
FR2374932A1 (fr) 1976-12-24 1978-07-21 Rhone Poulenc Ind Appareil a fibres creuses, utilisable notamment comme rein artificiel
US4201673A (en) 1977-07-04 1980-05-06 Terumo Corporation Apparatus for dialysis of solution
US4396510A (en) * 1981-01-08 1983-08-02 Bio-Med Corporation Mass transfer device
US4572724A (en) 1984-04-12 1986-02-25 Pall Corporation Blood filter
US4639353A (en) 1984-04-24 1987-01-27 Mitsubishi Rayon Co., Ltd. Blood oxygenator using a hollow-fiber membrane
DE8527694U1 (de) 1985-04-27 1987-02-19 Akzo Gmbh, 5600 Wuppertal Stoff- und/oder Wärmeaustauscher
ATE72142T1 (de) 1986-09-12 1992-02-15 Memtec Ltd Hohlfaserfilterpatrone und -verteiler.
SE454847B (sv) 1987-08-31 1988-06-06 Gambro Dialysatoren Anordning for diffusion och/eller filtrering samt forfarande for tillverkning av denna anordning
JPH01148266A (ja) 1987-12-04 1989-06-09 Terumo Corp 血液フィルター
JPH0696098B2 (ja) 1988-05-27 1994-11-30 株式会社クラレ 中空糸型流体処理装置
US5139741A (en) 1988-12-29 1992-08-18 Terumo Kabushiki Kaisha Blood processing apparatus of hollow fiber type
JPH0614965B2 (ja) 1989-01-10 1994-03-02 テルモ株式会社 人工肺
JPH0394928A (ja) * 1989-09-06 1991-04-19 Mitsubishi Heavy Ind Ltd 回転穿孔工具の同期調整方法
AU635414B2 (en) 1990-04-18 1993-03-18 Terumo Kabushiki Kaisha Hollow fiber type liquid processing apparatus
IT1240692B (it) 1990-05-02 1993-12-17 Dideco Spa Filtro per sangue in apparecchi medicali
FR2672513B1 (fr) 1991-02-13 1994-03-18 Tech Sep Procede et module perfectionnes de filtration en milieu liquide sous flux tangentiel instationnaire.
US5264171A (en) 1991-12-31 1993-11-23 Hoechst Celanese Corporation Method of making spiral-wound hollow fiber membrane fabric cartridges and modules having flow-directing baffles
US5919369A (en) 1992-02-06 1999-07-06 Hemocleanse, Inc. Hemofiltration and plasmafiltration devices and methods
WO1994003266A1 (en) 1992-08-03 1994-02-17 Maloney James V Jr Improved mass and thermal transfer means for use in heart lung machines, dialyzers, and other applications
GB2276566A (en) 1993-03-24 1994-10-05 Saitekku Kabushiki Kaisha Haemodialyser unit
US5618425A (en) 1993-04-30 1997-04-08 Terumo Kabushiki Kaisha Filtering apparatus with a pleated filtering element embedded in a filling material
US5346621A (en) 1993-05-19 1994-09-13 Avecor Cardiovascular, Inc. Hollow fiber blood oxygenator
US5798041A (en) 1995-09-06 1998-08-25 Hemasure, Inc. In-line liquid filtration device useable for blood, blood products or the like
US5632894A (en) 1994-06-24 1997-05-27 Gish Biomedical, Inc. Arterial blood filter with upwardly inclining delivery inlet conduit
US5626759A (en) 1994-08-01 1997-05-06 Regents Of The University Of Colorado Blood treatment device with moving membrane
DE69515766T2 (de) 1994-09-02 2000-07-06 Terumo K.K., Tokio/Tokyo Dialysegerät
US5500134A (en) 1995-03-16 1996-03-19 Dyna Flow, Inc. Microfiltration system with swirling flow around filter medium
US5525144A (en) 1995-04-20 1996-06-11 A/G Technology Corporation Tangential flow filtering and separating
US5651765A (en) 1995-04-27 1997-07-29 Avecor Cardiovascular Inc. Blood filter with concentric pleats and method of use
EP0765683B1 (de) 1995-09-25 1998-07-01 MEDOS Medizintechnik GmbH Vorrichtung zur Behandlung von Flüssigkeiten, insbesondere von Blut
JP3574902B2 (ja) 1996-11-15 2004-10-06 サイテック株式会社 中空糸型ダイアライザー
JP4115626B2 (ja) 1998-05-25 2008-07-09 旭化成クラレメディカル株式会社 中空糸膜型血液透析器の製造方法
US6113782A (en) 1998-07-28 2000-09-05 Terumo Cardiovascular Systems Corporation Potting of tubular bundles in housing
US6176904B1 (en) 1999-07-02 2001-01-23 Brij M. Gupta Blood filter

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219426A (en) * 1976-03-19 1980-08-26 Organon Teknika B.V. Dialysis device
US4220535A (en) * 1978-08-04 1980-09-02 Monsanto Company Multi-zoned hollow fiber permeator
DE2839937A1 (de) * 1978-09-14 1980-04-03 Sigdell Jan Erik Dr Hohlfaserdialysator mit dialysatfuehrung
WO1993013941A1 (en) * 1992-01-15 1993-07-22 The Dow Chemical Company Method of forming tube sheet for hollow fibers
US6074559A (en) * 1996-11-21 2000-06-13 Fresenius Medical Care Deutschland Gmbh Filter device having a hollow fiber bundle and associated sealing devices

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2954944A1 (de) 2014-06-12 2015-12-16 B. Braun Avitum AG Dialysator mit einem bündel an hohlfasern sowie verfahren zum herstellen einer solchen hohlfaser
DE102014108230A1 (de) 2014-06-12 2015-12-17 B. Braun Avitum Ag Dialysator mit einem Bündel an Hohlfasern sowie Verfahren zum Herstellen einer solchen Hohlfaser

Also Published As

Publication number Publication date
EP1406685A1 (en) 2004-04-14
JP2004529723A (ja) 2004-09-30
JP4036828B2 (ja) 2008-01-23
DE60227076D1 (de) 2008-07-24
AR033170A1 (es) 2003-12-03
JP2008029857A (ja) 2008-02-14
EP1406685B1 (en) 2008-06-11
TW553751B (en) 2003-09-21
US6623638B2 (en) 2003-09-23
US20030080047A1 (en) 2003-05-01
MXPA03010988A (es) 2004-02-27
ATE397946T1 (de) 2008-07-15

Similar Documents

Publication Publication Date Title
US6623638B2 (en) Hemodialyzer having improved dialysate perfusion
US20030075498A1 (en) Hemodialyzer headers
US20230093577A1 (en) Blood processing cartridges and systems, and methods for extracorporeal blood therapies
EP0176651B1 (en) Heat exchanger and blood oxygenating device furnished therewith
RU2292225C2 (ru) Гемодиафильтровальный/гемофильтровальный картридж
EP2313125B1 (en) Double fiber bundle dialyzer
US3728256A (en) Crossflow capillary dialyzer
KR100649260B1 (ko) 이중-스테이지 여과 카트리지
US4861485A (en) Hemodiafiltration device
JP2003518996A (ja) 二段式血液透析濾過カートリッジ
US5942112A (en) Hollow fiber ultradialyzer apparatus
GB1559203A (en) Diffuser for supplying liquid to a liquid treatment face of a device
US20080035568A1 (en) Apparatus and Method for Filtering Fluids
US20070119781A1 (en) Apparatus and method for enhanced hemodialysis performance
US10835868B2 (en) Filter device, system and method for filtration of fluids
JP4328902B2 (ja) オンライン型大量液置換型血液透析器
EP3167919B1 (en) Blood purifier
EP2363196B1 (en) Diffusion and/or filtration device
EP0157941A1 (en) Blood oxygenator using a hollow fiber membrane
JP2000070360A (ja) 中空糸膜型透析器
JP3257998B2 (ja) 中空糸膜型透析器
JP4237534B2 (ja) 血液浄化器
CN114053504A (zh) 一种方形医疗血液透析器
JPS6129360A (ja) 透析機能を有した人工肺
EP3473327A1 (en) Integrated fluid treatment device, and process using such device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/010988

Country of ref document: MX

Ref document number: 2003501527

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002776553

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002776553

Country of ref document: EP